Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts

Research output: Contribution to journalArticle

237 Citations (Scopus)

Abstract

Background: Mild cognitive impairment is increasingly recognized as an important public health problem associated with increased risk of developing dementia. Annual conversion rates, however, vary across different studies with clinic samples showing higher rates of conversion than community-based samples. Objectives: To establish whether the rates of conversion from mild cognitive impairment to dementia differed according to recruitment source and, if so, to investigate factors that might explain this discrepancy. Design: Rates and predictors of conversion were examined in a prospective longitudinal study at a single center. Setting: Among the participants, 46% were recruited from a clinical setting and 54% were recruited directly through community outreach. Participants: One hundred eleven individuals with mild cognitive impairment were followed up longitudinally for an average of 2.4 years (range, 0.5-4.0 years). Main Outcome Measures: Conversion from mild cognitive impairment to dementia. Results: During the follow-up period, 28 individuals progressed to dementia with a mean (SD) time to conversion of 2.19 (0.72) years. The clinic sample had an annual conversion rate of 13%, whereas the community sample had an annual conversion rate of 3%. In a Cox proportional hazards model, clinic recruitment source alone was associated with an increased hazard of incident dementia (hazard ratio = 3.50; 95% confidence interval, 1.31-9.18; P = .01). When other variables were added to the model, only baseline functional impairment as measured by the Clinical Dementia Rating Scale (and no demographic, cognitive, or neuroimaging variables or mild cognitive impairment subtype) accounted for the differences in conversion rates across the 2 cohorts. Conclusions: These findings add to the growing literature to suggest that the degree of functional impairment at baseline is an important predictor of conversion to dementia and may help explain differences in findings between epidemiological and clinic-based studies.

Original languageEnglish (US)
Pages (from-to)1151-1157
Number of pages7
JournalArchives of Neurology
Volume66
Issue number9
DOIs
StatePublished - Sep 2009

Fingerprint

Dementia
Community-Institutional Relations
Cognitive Dysfunction
Cohort
Clinic
Mild Cognitive Impairment
Progression
Proportional Hazards Models
Neuroimaging
Longitudinal Studies
Public Health
Demography
Outcome Assessment (Health Care)
Prospective Studies
Confidence Intervals

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

@article{ba37c71fa71e44e2b8aceafd40270faa,
title = "Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts",
abstract = "Background: Mild cognitive impairment is increasingly recognized as an important public health problem associated with increased risk of developing dementia. Annual conversion rates, however, vary across different studies with clinic samples showing higher rates of conversion than community-based samples. Objectives: To establish whether the rates of conversion from mild cognitive impairment to dementia differed according to recruitment source and, if so, to investigate factors that might explain this discrepancy. Design: Rates and predictors of conversion were examined in a prospective longitudinal study at a single center. Setting: Among the participants, 46{\%} were recruited from a clinical setting and 54{\%} were recruited directly through community outreach. Participants: One hundred eleven individuals with mild cognitive impairment were followed up longitudinally for an average of 2.4 years (range, 0.5-4.0 years). Main Outcome Measures: Conversion from mild cognitive impairment to dementia. Results: During the follow-up period, 28 individuals progressed to dementia with a mean (SD) time to conversion of 2.19 (0.72) years. The clinic sample had an annual conversion rate of 13{\%}, whereas the community sample had an annual conversion rate of 3{\%}. In a Cox proportional hazards model, clinic recruitment source alone was associated with an increased hazard of incident dementia (hazard ratio = 3.50; 95{\%} confidence interval, 1.31-9.18; P = .01). When other variables were added to the model, only baseline functional impairment as measured by the Clinical Dementia Rating Scale (and no demographic, cognitive, or neuroimaging variables or mild cognitive impairment subtype) accounted for the differences in conversion rates across the 2 cohorts. Conclusions: These findings add to the growing literature to suggest that the degree of functional impairment at baseline is an important predictor of conversion to dementia and may help explain differences in findings between epidemiological and clinic-based studies.",
author = "{Tomaszewski Farias}, {Sarah E} and Mungas, {Dan M} and Reed, {Bruce R} and Harvey, {Danielle J} and Charles DeCarli",
year = "2009",
month = "9",
doi = "10.1001/archneurol.2009.106",
language = "English (US)",
volume = "66",
pages = "1151--1157",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts

AU - Tomaszewski Farias, Sarah E

AU - Mungas, Dan M

AU - Reed, Bruce R

AU - Harvey, Danielle J

AU - DeCarli, Charles

PY - 2009/9

Y1 - 2009/9

N2 - Background: Mild cognitive impairment is increasingly recognized as an important public health problem associated with increased risk of developing dementia. Annual conversion rates, however, vary across different studies with clinic samples showing higher rates of conversion than community-based samples. Objectives: To establish whether the rates of conversion from mild cognitive impairment to dementia differed according to recruitment source and, if so, to investigate factors that might explain this discrepancy. Design: Rates and predictors of conversion were examined in a prospective longitudinal study at a single center. Setting: Among the participants, 46% were recruited from a clinical setting and 54% were recruited directly through community outreach. Participants: One hundred eleven individuals with mild cognitive impairment were followed up longitudinally for an average of 2.4 years (range, 0.5-4.0 years). Main Outcome Measures: Conversion from mild cognitive impairment to dementia. Results: During the follow-up period, 28 individuals progressed to dementia with a mean (SD) time to conversion of 2.19 (0.72) years. The clinic sample had an annual conversion rate of 13%, whereas the community sample had an annual conversion rate of 3%. In a Cox proportional hazards model, clinic recruitment source alone was associated with an increased hazard of incident dementia (hazard ratio = 3.50; 95% confidence interval, 1.31-9.18; P = .01). When other variables were added to the model, only baseline functional impairment as measured by the Clinical Dementia Rating Scale (and no demographic, cognitive, or neuroimaging variables or mild cognitive impairment subtype) accounted for the differences in conversion rates across the 2 cohorts. Conclusions: These findings add to the growing literature to suggest that the degree of functional impairment at baseline is an important predictor of conversion to dementia and may help explain differences in findings between epidemiological and clinic-based studies.

AB - Background: Mild cognitive impairment is increasingly recognized as an important public health problem associated with increased risk of developing dementia. Annual conversion rates, however, vary across different studies with clinic samples showing higher rates of conversion than community-based samples. Objectives: To establish whether the rates of conversion from mild cognitive impairment to dementia differed according to recruitment source and, if so, to investigate factors that might explain this discrepancy. Design: Rates and predictors of conversion were examined in a prospective longitudinal study at a single center. Setting: Among the participants, 46% were recruited from a clinical setting and 54% were recruited directly through community outreach. Participants: One hundred eleven individuals with mild cognitive impairment were followed up longitudinally for an average of 2.4 years (range, 0.5-4.0 years). Main Outcome Measures: Conversion from mild cognitive impairment to dementia. Results: During the follow-up period, 28 individuals progressed to dementia with a mean (SD) time to conversion of 2.19 (0.72) years. The clinic sample had an annual conversion rate of 13%, whereas the community sample had an annual conversion rate of 3%. In a Cox proportional hazards model, clinic recruitment source alone was associated with an increased hazard of incident dementia (hazard ratio = 3.50; 95% confidence interval, 1.31-9.18; P = .01). When other variables were added to the model, only baseline functional impairment as measured by the Clinical Dementia Rating Scale (and no demographic, cognitive, or neuroimaging variables or mild cognitive impairment subtype) accounted for the differences in conversion rates across the 2 cohorts. Conclusions: These findings add to the growing literature to suggest that the degree of functional impairment at baseline is an important predictor of conversion to dementia and may help explain differences in findings between epidemiological and clinic-based studies.

UR - http://www.scopus.com/inward/record.url?scp=70349094526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349094526&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2009.106

DO - 10.1001/archneurol.2009.106

M3 - Article

C2 - 19752306

AN - SCOPUS:70349094526

VL - 66

SP - 1151

EP - 1157

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 9

ER -